Vishal Nirmiti IPO
MainboardListed

GMP history

The grey market premium of the Vishal Nirmiti IPO, day by day, against the ₹220 upper price band. Last figure from 8 Oct 2026.

₹2
0.91% over the issue price

How the GMP moved

The GMP of the Vishal Nirmiti IPO started at ₹2 on 28 Sep 2026 and ended ₹2 before listing, unchanged over 11 days.

It peaked at ₹20 on 1 Oct 2026 and was lowest at ₹2 on 28 Sep 2026. In the last 4 days it held steady.

From one recorded day to the next, the GMP rose on 3 days, fell on 1 day and held on 6 days. The largest one-day move was a fall of ₹18 on 5 Oct 2026.

On the day bidding opened, 30 Sep 2026, the GMP was ₹10; on the day it closed, 5 Oct 2026, it was ₹2.

Bidding closed with the issue subscribed 1.79× overall.

At the ₹220 upper band, the last GMP pointed to a 0.91% gain; the shares listed down 2.27%, so the GMP overstated the gain.

What it means for one lot

One lot is 68 shares, ₹14,960 at the ₹220 upper band.

The last GMP pointed to a gain of ₹136 on one lot. The shares listed at about ₹215.01, which made a loss of ₹340 on one lot.

At the highest GMP, ₹20, the figure for one lot was a gain of ₹1,360; at the lowest, ₹2, it was a gain of ₹136.

Implied listing price
₹222
₹220 upper band plus GMP
Highest GMP
₹20
1 Oct 2026
Lowest GMP
₹2
28 Sep 2026
Days tracked
11
one figure a day

Grey Market Premium Trend

GMP last updated: 8 Oct 2026, 9:37 AM IST

₹2
Final GMP
-2.27%
Actual Listing Gain
0.9%
GMP-Implied Gain
₹208 - ₹220
Price Band
Listed on 8 Oct 2026. The last GMP pointed to 0.91%; the actual listing gain was -2.27%.
How accurate is GMP?

Day by day

DateGMPImplied listingChange
8 Oct 2026₹2₹222–
7 Oct 2026₹2₹222–
6 Oct 2026₹2₹222–
5 Oct 2026₹2₹222−₹18
4 Oct 2026₹20₹240–
3 Oct 2026₹20₹240–
2 Oct 2026₹20₹240–
1 Oct 2026₹20₹240+₹10
30 Sep 2026₹10₹230+₹4
29 Sep 2026₹6₹226+₹4
28 Sep 2026₹2₹222–

GMP is an unofficial price from the grey market before the shares list. It is not a guarantee of the listing price and can move sharply from one day to the next. Read how we collect it in our methodology.